Dolutegravir based antiretroviral therapy compared to other combined antiretroviral regimens for the treatment of HIV-infected naive patients: A systematic review and meta-analysis-Reference-Cited by-同舟云学术

Dolutegravir based antiretroviral therapy compared to other combined antiretroviral regimens for the treatment of HIV-infected naive patients: A systematic review and meta-analysis

Published:2019-09-10 Issue:9 Volume:14 Page:e0222229
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Cruciani Mario^ORCID,Parisi Saverio G.

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference36 articles.

1. Antiretroviral therapy and management of HIV infection;PA Volberding;Lancet,2010

2. Why are baseline HIV RNA levels 100,000 copies/mL or greater associated with mortality after the initiation of antiretroviral therapy?;E Wood;J Acquir Immune Defic Syndr,2005

3. Dolutegravir: a next-generation integrase inhibitor for treatment of HIV infection;DA Osterholzer;Clin Infect Dis,2014

4. Combination dolutegravir-abacavir-lamivudine in the management of HIV/AIDS: clinical utility and patient considerations;M Cruciani;Patient Prefer Adherence,2015

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. “No One Needs to be Forced”: Qualitative Insights on Competing Priorities between Antiretroviral Therapy and Reproductive Health Planning during the Dolutegravir Rollout;AIDS and Behavior;2024-07-31

2. Integrase inhibitors: current protagonists in antiretroviral therapy;Immunotherapy;2023-12

3. Effect of dolutegravir-based versus efavirenz-based antiretroviral therapy on excessive weight gain in adult treatment-naïve HIV patients at Matsanjeni Health Center, Eswatini: A retrospective cohort study;2023-11-22

4. Prevalence and factors associated with suboptimal adherence to dolutegravir-based regimens among people living with HIV in a specialized clinic in Kampala, Uganda;2023-11-01

5. Current ART, determinants for virologic failure and implications for HIV drug resistance: an umbrella review;AIDS Research and Therapy;2023-10-27